China NT Pharma Group Company Limited provided group earnings guidance for the six months ended 30 June 2020. The Board announced the Shareholders and potential investors that, based on the information currently available to the Group, the Group is expected to record a loss for the six months ended 30 June 2020. As compared with the corresponding period in 2019, the Group may turn profit into loss.